135 related articles for article (PubMed ID: 2547933)
1. A role for histamine and H2-receptors in opioid antinociception.
Gogas KR; Hough LB; Eberle NB; Lyon RA; Glick SD; Ward SJ; Young RC; Parsons ME
J Pharmacol Exp Ther; 1989 Aug; 250(2):476-84. PubMed ID: 2547933
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
Gogas KR; Hough LB
J Pharmacol Exp Ther; 1989 Jan; 248(1):262-7. PubMed ID: 2563290
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of morphine antinociception by centrally administered histamine H2 receptor antagonists.
Hough LB; Nalwalk JW
Eur J Pharmacol; 1992 Apr; 215(1):69-74. PubMed ID: 1355443
[TBL] [Abstract][Full Text] [Related]
5. Importance of histamine H2 receptors in restraint-morphine interactions.
Nalwalk JW; Hough LB
Life Sci; 1995; 57(13):PL153-8. PubMed ID: 7674814
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice.
Mobarakeh JI; Takahashi K; Sakurada S; Kuramasu A; Yanai K
Neuropharmacology; 2006 Sep; 51(3):612-22. PubMed ID: 16806305
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of 2-deoxy-D-glucose antinociception, but not hyperphagia by zolantidine, a histamine (H2) receptor antagonist.
Koch JE; Hough LB; Bodnar RJ
Pharmacol Biochem Behav; 1992 Feb; 41(2):371-6. PubMed ID: 1349437
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
9. Two histamine H2 receptor antagonists, zolantidine and cimetidine, modulate nociception in cholestatic rats.
Hasanein P
J Psychopharmacol; 2011 Feb; 25(2):281-8. PubMed ID: 19825905
[TBL] [Abstract][Full Text] [Related]
10. Zolantidine-induced attenuation of morphine antinociception in rhesus monkeys.
Hough LB; Nalwalk JW; Battles AH
Brain Res; 1990 Aug; 526(1):153-5. PubMed ID: 1981852
[TBL] [Abstract][Full Text] [Related]
11. Modulation of morphine antinociception by the brain-penetrating H2 antagonist zolantidine: detailed characterization in five nociceptive test systems.
Nalwalk JW; Koch JE; Barke KE; Bodnar RJ; Hough LB
Pharmacol Biochem Behav; 1995 Mar; 50(3):421-9. PubMed ID: 7617681
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice.
Mobarakeh JI; Takahashi K; Sakurada S; Nishino S; Watanabe H; Kato M; Naghdi N; Yanai K
Pain; 2005 Nov; 118(1-2):254-62. PubMed ID: 16202530
[TBL] [Abstract][Full Text] [Related]
13. The involvement of histamine H2-receptors in restraint-induced antinociception in male mice.
Wong CL
Methods Find Exp Clin Pharmacol; 1993; 15(6):351-6. PubMed ID: 7901462
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
15. Involvement of histaminergic system in the discriminative stimulus effects of morphine.
Mori T; Narita M; Onodera K; Suzuki T
Eur J Pharmacol; 2004 May; 491(2-3):169-72. PubMed ID: 15140633
[TBL] [Abstract][Full Text] [Related]
16. Cross-tolerance and cross-sensitization between morphine analgesia and naloxone-sensitive and cimetidine-sensitive stress-induced analgesia.
Weinstein IJ; Hough LB; Gogas KR
J Pharmacol Exp Ther; 1988 Jan; 244(1):253-8. PubMed ID: 3336002
[TBL] [Abstract][Full Text] [Related]
17. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
18. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
19. [Direct involvement of the supraspinal phosphoinositide 3-kinase/phospholipase C gamma 1 pathway in the mu-opioid receptor agonist-induced supraspinal antinociception in the mouse].
Narita M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Jun; 23(3):121-8. PubMed ID: 12884752
[TBL] [Abstract][Full Text] [Related]
20. H2-receptor-mediated stress-induced analgesia is dependent on neither pituitary nor adrenal activation.
Gogas KR; Hough LB
Pharmacol Biochem Behav; 1988 Jul; 30(3):791-4. PubMed ID: 2905473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
